Pantarhei Oncology B.V.: Clinical Trials

3 completed. 2 Phase 1, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	2	Completed 2
Phase 2	2	Completed 2

Follow Pantarhei Oncology B.V.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist. Estetrol, Placebo Oral Tablet - Prostatic Neoplasm	Phase 2	Completed	Pantarhei Oncology B.V.	63	2018-04-16	2021-06-18
Assessment of Safety and Efficacy of Estetrol in Postmenopausal Women With Advanced Estrogen Receptor Positive (ER+) Breast Cancer Estetrol - Breast Neoplasms	Phase 1 / Phase 2	Completed	Pantarhei Oncology B.V.	12	2017-06-01	2021-06-18
Evaluation of Safety and Efficacy of Estetrol in Healthy Men estetrol, placebo - Prostatic Neoplasms	Phase 1	Completed	Pantarhei Oncology B.V.	45	2016-03-01	2017-02-09

Conditions studied

Prostatic Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Hot Flashes (1)

Interventions

Estetrol (3)

Countries

Netherlands (2)  ·  Germany (1)

Top investigators

Tjeert Mensinga, MD, PhD (1)

Results publications

PMID 18464023, PMID 24932461, PMID 24997853, PMID 25961355, PMID 29931320